Literature DB >> 22923750

Primary anti-phospholipid syndrome: any role for serum complement levels in predicting pregnancy complications?

Rossella Reggia1, Tamara Ziglioli, Laura Andreoli, Francesca Bellisai, Annamaria Iuliano, Maria Gerosa, Veronique Ramoni, Chiara Tani, Antonio Brucato, Mauro Galeazzi, Marta Mosca, Roberto Caporali, Pier Luigi Meroni, Angela Tincani.   

Abstract

OBJECTIVE: To evaluate the association between serum complement levels (C3 and C4) and obstetric complications.
METHODS: Fifty-seven pregnancies in primary APS (PAPS) patients were compared with 49 pregnancies in patients with UCTD and SS. A group of 175 healthy pregnant women were studied to calculate a normality range for C3 and C4 during pregnancy. Such a range was applied to define hypocomplementaemia in PAPS and UCTD/SS.
RESULTS: Both groups of patients (PAPS and UCTD/SS) showed significantly lower levels of C3 and C4 in each trimester as compared with healthy women; conversely, no significant difference was found between PAPS and UCTD/SS. Comparing PAPS pregnancies with and without complications, no difference was found in the prevalence of low C3 or low C4.
CONCLUSION: No association was found between hypocomplementaemia and obstetric complications in PAPS. However, both cases of pre-eclampsia were characterized by low C3 throughout pregnancy. There is evidence that the complement system is a contributor to the mechanisms of aPL-mediated damage, but its predictive role on the final pregnancy outcome does not seem to be of major impact.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22923750     DOI: 10.1093/rheumatology/kes225

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  13 in total

1.  Maternal and Fetal Outcomes of Pregnancies in Women with Atypical Hemolytic Uremic Syndrome.

Authors:  Martina Gaggl; Christof Aigner; Dorottya Csuka; Ágnes Szilágyi; Zoltán Prohászka; Renate Kain; Natalja Haninger; Maarten Knechtelsdorfer; Raute Sunder-Plassmann; Gere Sunder-Plassmann; Alice Schmidt
Journal:  J Am Soc Nephrol       Date:  2017-12-27       Impact factor: 10.121

2.  Complement activation predicts adverse pregnancy outcome in patients with systemic lupus erythematosus and/or antiphospholipid antibodies.

Authors:  Mimi Y Kim; Marta M Guerra; Elianna Kaplowitz; Carl A Laskin; Michelle Petri; D Ware Branch; Michael D Lockshin; Lisa R Sammaritano; Joan T Merrill; T Flint Porter; Allen Sawitzke; Anne M Lynch; Jill P Buyon; Jane E Salmon
Journal:  Ann Rheum Dis       Date:  2018-01-25       Impact factor: 19.103

Review 3.  Additional Treatments for High-Risk Obstetric Antiphospholipid Syndrome: a Comprehensive Review.

Authors:  Amelia Ruffatti; Ariela Hoxha; Maria Favaro; Marta Tonello; Anna Colpo; Umberto Cucchini; Alessandra Banzato; Vittorio Pengo
Journal:  Clin Rev Allergy Immunol       Date:  2017-08       Impact factor: 8.667

4.  CD8+DR+ T-Cells and C3 Complement Serum Concentration as Potential Biomarkers in Thrombotic Antiphospholipid Syndrome.

Authors:  Elizabeth Sarmiento; Jonathan Dale; Mauricio Arraya; Antonio Gallego; Nallibe Lanio; Joaquin Navarro; Javier Carbone
Journal:  Autoimmune Dis       Date:  2014-05-29

5.  Pathogenic Role of Complement in Antiphospholipid Syndrome and Therapeutic Implications.

Authors:  Francesco Tedesco; Maria Orietta Borghi; Maria Gerosa; Cecilia Beatrice Chighizola; Paolo Macor; Paola Adele Lonati; Alessandro Gulino; Beatrice Belmonte; Pier Luigi Meroni
Journal:  Front Immunol       Date:  2018-06-19       Impact factor: 7.561

Review 6.  Complement in the Pathophysiology of the Antiphospholipid Syndrome.

Authors:  Shruti Chaturvedi; Robert A Brodsky; Keith R McCrae
Journal:  Front Immunol       Date:  2019-03-14       Impact factor: 7.561

7.  Triple Antiphospholipid (aPL) Antibodies Positivity Is Associated With Pregnancy Complications in aPL Carriers: A Multicenter Study on 62 Pregnancies.

Authors:  Maria-Grazia Lazzaroni; Micaela Fredi; Laura Andreoli; Cecilia Beatrice Chighizola; Teresa Del Ross; Maria Gerosa; Anna Kuzenko; Maria-Gabriella Raimondo; Andrea Lojacono; Francesca Ramazzotto; Sonia Zatti; Laura Trespidi; Pier-Luigi Meroni; Vittorio Pengo; Amelia Ruffatti; Angela Tincani
Journal:  Front Immunol       Date:  2019-08-14       Impact factor: 7.561

8.  Risk Factors for Adverse Maternal and Fetal Outcomes in Women With Confirmed aPL Positivity: Results From a Multicenter Study of 283 Pregnancies.

Authors:  Micaela Fredi; Laura Andreoli; Elena Aggogeri; Elisa Bettiga; Maria Grazia Lazzaroni; Véronique Le Guern; Andrea Lojacono; Nathalie Morel; Jean Charles Piette; Sonia Zatti; Nathalie Costedoat-Chalumeau; Angela Tincani
Journal:  Front Immunol       Date:  2018-05-07       Impact factor: 7.561

Review 9.  Essential Role of Complement in Pregnancy: From Implantation to Parturition and Beyond.

Authors:  Guillermina Girardi; Joshua J Lingo; Sherry D Fleming; Jean F Regal
Journal:  Front Immunol       Date:  2020-07-31       Impact factor: 7.561

Review 10.  The Complement System in the Pathophysiology of Pregnancy and in Systemic Autoimmune Rheumatic Diseases During Pregnancy.

Authors:  Cecilia Beatrice Chighizola; Paola Adele Lonati; Laura Trespidi; Pier Luigi Meroni; Francesco Tedesco
Journal:  Front Immunol       Date:  2020-08-27       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.